Having access to high-titer, purified viruses is important for vaccine development and gene therapy research. However, obtaining these essential materials can be challenging as the process for culturing, purifying, and titering a viral preparation can be time consuming and costly, requiring technical expertise, specialized equipment, and a broad range of supporting biomaterials and reagents.
To help researchers overcome this critical bottleneck, ATCC offers high-titer, purified preparations of clinically relevant viruses. With each of these ready-to-use preparations, you can expect:
- High titer – Infectious titer of >107 TCID50/mL, CEID50/mL, or PFU/mL
- Quantified genome copy number – Evaluated by Droplet Digital™ PCR
- Purity – Tangential flow filtration or gradient ultracentrifugation
- Authenticity – Verified identity and viability
Explore our collection today to discover how you can incorporate high-titer, purified viruses in your research and development applications.